• Preview of New Chemical Approval Form and Risk ScreeningExcel workbook preview

Chemicals and Hazardous Materials (REACH, TSCA, EPCRA)

New Chemical Approval Form and Risk Screening

$17.99 Free XLSX
Excel workbook · 13 KB

3 downloads per free account, no card needed.

Need more than 3? Get all 300 templates for $249 One payment, lifetime access, including every template added later.

Who this is for

For the HSE or environment manager who has to say yes or no to a new product today and wants a decision that will stand up when an auditor asks why.

What is inside

  • Request form with product, supplier, use, quantity, location and SDS details
  • 15 screening questions with points and four stop rules (CMR, SVHC, restricted, PFAS)
  • Live total score and decision: Low, Medium, High or refer for substitution review
  • Approval block for requester, HSE and environment sign-off with conditions
  • Request log with 10 sample requests and days-to-decision formula
  • Dropdowns, colour rules, 20 blank log rows, prints one page wide

How to use it: Copy the Screening sheet for each request, answer every question from the SDS, and record the result in the Request log. Adjust the points and thresholds once, before first use.

Files & formats
  • XLSXnew-chemical-approval-form-and-risk-screening-template.xlsx13 KB

Opens in Microsoft Word or Excel, Google Docs or Sheets and LibreOffice. Delivered instantly from your browser.

Free downloads & full access

Every account gets 3 free downloads. Re-downloading a template you already have does not count. This template on its own is $17.99, and buying it keeps your free downloads for something else. Full access is a one-time $249 for all 300 templates, for life.

Bought with a different email? Open your account and enter your order number.

Licence

Use and adapt the document inside your own organisation or for your own clients. Do not resell or republish the templates themselves. These templates are original working documents built on the public law or guidance named here. They are not legal advice and are not endorsed by the regulator or publisher.